{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:48:46Z","timestamp":1773982126535,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760115"],"award-info":[{"award-number":["81760115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81460118"],"award-info":[{"award-number":["81460118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Education Department Scientific Research Foundation of Jiangxi Province","award":["GJJ160039"],"award-info":[{"award-number":["GJJ160039"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.intimp.2018.05.024","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T22:29:41Z","timestamp":1527632981000},"page":"100-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice"],"prefix":"10.1016","volume":"61","author":[{"given":"Xiaoquan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianxin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2018.05.024_bb0005","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1086\/314502","article-title":"Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities","volume":"178","author":"Mertz","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2018.05.024_bb0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/OLQ.0b013e318269cf90","article-title":"Prevalence and associations of genital ulcer and urethral pathogens in men presenting with genital ulcer syndrome to primary health care clinics in South Africa","volume":"39","author":"Lewis","year":"2012","journal-title":"Sex. Transm. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2018.05.024_bb0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/CMR.00043-15","article-title":"Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding","volume":"29","author":"Johnston","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2018.05.024_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00002030-200202150-00018","article-title":"Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania","volume":"16","author":"Rodr\u00edguez","year":"2002","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.intimp.2018.05.024_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114989","article-title":"Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2018.05.024_bb0030","first-page":"844","article-title":"Vaccination to reduce reactivation of herpes simplex virus type 2","volume":"215","author":"Cohen","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"26","key":"10.1016\/j.intimp.2018.05.024_bb0035","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2015.12.076","article-title":"Status of vaccine research and development of vaccines for herpes simplex virus","volume":"34","author":"Johnston","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.intimp.2018.05.024_bb0040","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/erv.12.129","article-title":"The challenge of developing a herpes simplex virus 2 vaccine","volume":"11","author":"Dropulic","year":"2012","journal-title":"Expert Review of Vaccines"},{"issue":"21","key":"10.1016\/j.intimp.2018.05.024_bb0045","doi-asserted-by":"crossref","first-page":"12612","DOI":"10.1128\/JVI.01930-14","article-title":"Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans","volume":"88","author":"Cairns","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2018.05.024_bb0050","article-title":"Novel therapeutic vaccine for genital herpes reduces genital HSV-2 shedding","author":"Wald","year":"2013"},{"key":"10.1016\/j.intimp.2018.05.024_bb0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virol.2014.07.018","article-title":"Identification of novel virus-specific antigens by CD4+ and CD8+ T cells from asymptomatic HSV-2 seropositive and seronegative donors","volume":"464\u2013465","author":"Long","year":"2014","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.intimp.2018.05.024_bb0060","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.02745-12","article-title":"An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in guinea pigs","volume":"87","author":"Skoberne","year":"2013","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.intimp.2018.05.024_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076407","article-title":"A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice","volume":"8","author":"Dutton","year":"2013","journal-title":"PLoS One"},{"issue":"49","key":"10.1016\/j.intimp.2018.05.024_bb0070","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1016\/j.vaccine.2012.09.057","article-title":"A Vaxfectin\u00ae-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes","volume":"30","author":"Veselenak","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2018.05.024_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121518","article-title":"Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs","volume":"10","author":"Bernard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2018.05.024_bb0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.intimp.2016.08.001","article-title":"Augmentation of T helper type 1 immune response through intestinal immunity in murine cutaneous herpes simplex virus type 1 infection by probiotic Lactobacillus plantarum strain 06CC2","volume":"39","author":"Matsusaki","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2018.05.024_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.micpath.2012.11.001","article-title":"HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection","volume":"58","author":"Roth","year":"2013","journal-title":"Microb. Pathog."},{"issue":"21","key":"10.1016\/j.intimp.2018.05.024_bb0090","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1074\/jbc.M511571200","article-title":"Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein","volume":"281","author":"Parra-Lopez","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2018.05.024_bb0095","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"issue":"50","key":"10.1016\/j.intimp.2018.05.024_bb0100","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1016\/j.vaccine.2007.09.033","article-title":"Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate","volume":"25","author":"Junco","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.intimp.2018.05.024_bb0105","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1158\/1078-0432.CCR-11-3185","article-title":"Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response","volume":"18","author":"Godet","year":"2012","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"24","key":"10.1016\/j.intimp.2018.05.024_bb0110","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.vaccine.2014.02.024","article-title":"Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates","volume":"32","author":"Fraser","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2018.05.024_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.1500198","article-title":"Immunization with HSV-2 gB-CCL19 fusion constructs protects mice against lethal vaginal challenge","volume":"195","author":"Yan","year":"2015","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.intimp.2018.05.024_bb0120","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1128\/JVI.77.23.12742-12752.2003","article-title":"Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1","volume":"77","author":"Toka","year":"2003","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.intimp.2018.05.024_bb0125","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.1300120","article-title":"CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue","volume":"191","author":"Hu","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2018.05.024_bb0130","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/JVI.03200-13","article-title":"Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B","volume":"88","author":"Cairns","year":"2014","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2018.05.024_bb0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vaccine.2004.05.011","article-title":"Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responses","volume":"23","author":"Cooper","year":"2004","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.intimp.2018.05.024_bb0140","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.4049\/jimmunol.156.10.3901","article-title":"Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled","volume":"156","author":"Tigges","year":"1996","journal-title":"J. Immunol."},{"issue":"9\u201310","key":"10.1016\/j.intimp.2018.05.024_bb0145","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0264-410X(98)00326-0","article-title":"A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D1","volume":"17","author":"Cruz","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.intimp.2018.05.024_bb0150","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/jit651","article-title":"Correlate of immune protection against HSV-1 genital disease in vaccinated women","volume":"209","author":"Belshe","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2018.05.024_bb0155","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.4049\/jimmunol.159.7.3638","article-title":"Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens","volume":"159","author":"Okada","year":"1997","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2018.05.024_bb0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0264-410X(01)00270-5","article-title":"Adjuvant effects of IL-1\u03b2, IL-2, IL-8, IL-15, IFN-\u03b1, IFN-\u03b3TGF-\u03b24 and lymphotactin on DNA vaccination against Eimeria acervulina","volume":"20","author":"Min","year":"2001","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.intimp.2018.05.024_bb0165","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1128\/JVI.00302-12","article-title":"A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections","volume":"86","author":"Chiuppesi","year":"2012","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.intimp.2018.05.024_bb0170","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1128\/JVI.01130-14","article-title":"Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes","volume":"88","author":"Awasthi","year":"2014","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2018.05.024_bb0175","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/315324","article-title":"Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins","volume":"181","author":"Diethelm-Okita","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2018.05.024_bb0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.intimp.2012.10.019","article-title":"TLR agonists are highly effective at eliciting functional memory CTLs of effector memory phenotype in peptide immunization","volume":"15","author":"Smyth","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2018.05.024_bb0185","series-title":"Janeway's Immunobiology","author":"Murphy","year":"2016"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918302352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918302352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T21:46:13Z","timestamp":1693691173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918302352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"alternative-id":["S1567576918302352"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.05.024","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}